EUVIMEDEUVIMED entdecken
FallberichtOpen Access

MLH1 c.27G>A (p.Arg9=) is a synonymous likely/pathogenic variant underlying variably mosaic constitutional MLH1 methylation in Lynch syndrome

Rocio Alvarez, Paula Climent-Cantó, GiWon Shin, Francesca Paola Aguirre, Lisa Zhou, Dennis J Hazelett, Brent K Larson, Covadonga Vara, Gabriel Capellá, Víctor Lorca Castellanos, Pilar Garre Rubio, Françoise Desseigne und 6 weitere

Familial Cancer · 2025

DOI: 10.1007/s10689-025-00482-8 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Familial Cancer, 2025. Verfasst von Rocio Alvarez und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, DNA Methylation, Mosaicism, MutL Protein Homolog 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, USA National Cancer Institute, Instituto de Salud Carlos III and European Regional Development FEDER.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The MLH1 synonymous variant c.27G>A (p.Arg9 =) has been reported in four index cases with suspected Lynch syndrome, but is variably classified as "likely pathogenic" or "variant of uncertain significance" due to insubstantial clinical and functional evidence. We report three new MLH1 c.27G>A index cases with family histories fulfilling Amsterdam criteria for Lynch syndrome and reassessed collective evidence for pathogenicity. Two are European families from the UK (two siblings) and Spain (three members spanning three generations), and the third is a proband from Mongolia, the first non-European reported with this variant. Blood-based constitutional MLH1 methylation testing in six heterozygotes from the three families revealed varying levels of mosaic methylation, even within the same family, ranging from extremely low (≤ 1%) to ~ 16%. Two heterozygotes with blood methylation ≤ 1% had elevated methylation (5-8%) in normal colon distant from their colon cancers. Mosaic constitutional MLH1 methylation was linked in cis to the variant c.27A allele in all six heterozygotes and segregated together across generations. Three archived early-onset colon cancers available from three heterozygotes (UK siblings, Mongolian proband) each displayed MLH1 loss, MLH1 hypermethylation, and loss-of-heterozygosity of the wild-type c.27G allele, consistent with methylated c.27A alleles within a fraction of colon cells predisposing to tumorigenesis. Nanopore sequencing in the two European families found no significant shared ancestry and no other candidate variants. Multifactorial data collated from these and prior observational studies now provide sufficient evidence for the classification of MLH1 c.27G>A as likely/pathogenic via a functional mechanism of variably mosaic "secondary" constitutional MLH1 epimutation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal Neoplasms, Hereditary NonpolyposisDNA MethylationMosaicismMutL Protein Homolog 1AdultFemaleHumansMaleMiddle AgedHeterozygotePedigree

Stichwörter der Autor:innen

Lynch syndromeMosaicismSecondary constitutional MLH1 epimutation

Substanzen

MLH1 protein, humanMutL Protein Homolog 1

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
  • Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908, Barcelona, Spain.
  • Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.
  • McDonnell Genome Institute, Washington University School of Medicine, Saint Louis, MO, 63108, USA.
  • Department of Computational Biology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
  • Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.

ORCID-Profile: Megan P Hitchins

Förderung

  • NCI NIH HHS
  • USA National Cancer Institute
  • Instituto de Salud Carlos III and European Regional Development FEDER
  • Spanish Ministry of Science

Zitieren

APA

Alvarez, R., Climent-Cantó, P., Shin, G., Aguirre, F. P., Zhou, L., Hazelett, D. J., Larson, B. K., Vara, C., Capellá, G., Castellanos, V. L., Rubio, P. G., Desseigne, F., Ji, H., Cook, J., Durkie, M., Pineda, M., Leclerc, J., & Hitchins, M. P. (2025). MLH1 c.27G>A (p.Arg9=) is a synonymous likely/pathogenic variant underlying variably mosaic constitutional MLH1 methylation in Lynch syndrome. Familial Cancer. https://doi.org/10.1007/s10689-025-00482-8

Vancouver

Alvarez R, Climent-Cantó P, Shin G, Aguirre FP, Zhou L, Hazelett DJ, et al. MLH1 c.27G>A (p.Arg9=) is a synonymous likely/pathogenic variant underlying variably mosaic constitutional MLH1 methylation in Lynch syndrome. Familial Cancer. 2025. doi:10.1007/s10689-025-00482-8

BibTeX
@article{Alvarez2025,
  author = {Alvarez, Rocio and Climent-Cantó, Paula and Shin, GiWon and Aguirre, Francesca Paola and Zhou, Lisa and Hazelett, Dennis J and Larson, Brent K and Vara, Covadonga and Capellá, Gabriel and Castellanos, Víctor Lorca and Rubio, Pilar Garre and Desseigne, Françoise and Ji, Hanlee and Cook, Jackie and Durkie, Miranda and Pineda, Marta and Leclerc, Julie and Hitchins, Megan P},
  title = {MLH1 c.27G>A (p.Arg9=) is a synonymous likely/pathogenic variant underlying variably mosaic constitutional MLH1 methylation in Lynch syndrome},
  journal = {Familial Cancer},
  year = {2025},
  doi = {10.1007/s10689-025-00482-8}
}
Kostenlos starten →